Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.
RMD Open
; 9(1)2023 02.
Article
in En
| MEDLINE
| ID: mdl-36746531
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Raynaud Disease
/
Scleroderma, Systemic
/
Autoantibodies
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
RMD Open
Year:
2023
Type:
Article
Affiliation country:
Netherlands